Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $989000.0.

  • InspireMD's Change in Account Payables rose 820.57% to $989000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 488.74%. This contributed to the annual value of $1.2 million for FY2024, which is 11973.68% up from last year.
  • According to the latest figures from Q3 2025, InspireMD's Change in Account Payables is $989000.0, which was up 820.57% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, InspireMD's Change in Account Payables peaked at $1.7 million during Q2 2025, and registered a low of -$1.0 million during Q1 2025.
  • Moreover, its 5-year median value for Change in Account Payables was $337000.0 (2021), whereas its average is $260368.4.
  • Per our database at Business Quant, InspireMD's Change in Account Payables crashed by 18069.2% in 2022 and then skyrocketed by 192800.0% in 2024.
  • Over the past 5 years, InspireMD's Change in Account Payables (Quarter) stood at $337000.0 in 2021, then soared by 329.38% to $1.4 million in 2022, then tumbled by 35.66% to $931000.0 in 2023, then crashed by 70.03% to $279000.0 in 2024, then surged by 254.48% to $989000.0 in 2025.
  • Its Change in Account Payables was $989000.0 in Q3 2025, compared to $1.7 million in Q2 2025 and -$1.0 million in Q1 2025.